UK markets closed

BRAIN Biotech AG (0RFI.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
4.4097-0.7703 (-14.87%)
At close: 04:26PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.32
52-week change 3N/A
S&P500 52-week change 3-16.62%
52-week high 34.4097
52-week low 34.4097
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 518.06M
Implied shares outstanding 6N/A
Float 811.19M
% held by insiders 150.80%
% held by institutions 125.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin -17.31%
Operating margin (ttm)-12.25%

Management effectiveness

Return on assets (ttm)-5.27%
Return on equity (ttm)-27.95%

Income statement

Revenue (ttm)47.53M
Revenue per share (ttm)2.22
Quarterly revenue growth (yoy)30.70%
Gross profit (ttm)21.82M
EBITDA -2.28M
Net income avi to common (ttm)-8.23M
Diluted EPS (ttm)-0.3690
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.31M
Total cash per share (mrq)0.61
Total debt (mrq)N/A
Total debt/equity (mrq)138.37
Current ratio (mrq)1.85
Book value per share (mrq)1.50

Cash flow statement

Operating cash flow (ttm)-1.94M
Levered free cash flow (ttm)1.1M